Image Credit: STAT News STAT+: Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease Watchdoq January 10, 2025 Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease. Read Full Article
